Grifols reported strong third-quarter 2026 results with revenue exceeding €2 billion, a 10% rise in EBITDA, and a 28% increase in net profit. The company’s leverage has improved to below 4x, and it has started paying dividends, signaling improved financial stability. Strategic expansion into Egypt aims to diversify plasma sourcing and reduce costs, supporting margin growth through geographic diversification. Despite some volatility and high leverage, Grifols trades at a reasonable 12.7x P/E ratio, making it a speculative 'BUY' with an expected annual upside of over 20% if growth continues.
Grifols' recent financial performance is noted here as context for readers. For those following the health sector, 118 of 150 US health stocks traded on Pluang rose today. Notable movers include TWST at USD 136.75 with an 82% buy order activity and a 5.97% gain, DFTX at USD 33.98 up 5.96%, and MRVI at USD 7.62 with a 5.91% increase, as of Nov 03, 2026 23:21 WIB.
Vencora has acquired CT InsureTech, a leading insurance technology provider with offices in London, Buenos Aires, and Mexico City. This acquisition strengthens Vencora's insurance technology offerings and expands its presence in Latin America and Eur...
Vencora has acquired CT InsureTech, a leading provider of insurance technology and services with offices in London, Buenos Aires, and Mexico City. This acquisition expands Vencora's portfolio and presence in Latin America and the UK, strengthening it...
The Hospitality Show, a key event for hotel operations, will return to Las Vegas from March 27–29, 2028, at the Las Vegas Convention Center. This marks a return to its original location and an earlier spring date, chosen to better align with hospital...
FarmQA and Planet Labs have partnered to develop AI-powered agronomic tools for enterprise agriculture, starting with a sugar beet yield estimation model. This model combines Planet's satellite imagery with FarmQA's field-verified agronomic data to p...
The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...
